{
  "DOI": "10.1007/s10689-022-00317-w",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-022-00317-w",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eVariants in hereditary cancer risk genes are frequently identified following tumor-based DNA sequencing and represent an opportunity to diagnose hereditary cancer. We implemented an automated hereditary cancer screening program in a large HMO for all patients who underwent tumor-based DNA sequencing to identify patients with hereditary cancer and determine if this approach augmented existing genetic counseling approaches driven by personal/family history criteria. Regular automated searches of a centralized tumor DNA variant database were performed for ATM, BRCA1, BRCA2, MLH1, MSH2, MSH6, PALB2, and/or PMS2 variants, and germline hereditary cancer gene panel testing was offered to patients with tumor variants who had never undergone germline testing. Patients completing germline testing due to their tumor DNA test results were considered part of the tumor DNA safety net. Patients previously completing germline testing via traditional genetic counseling and tumor DNA safety net were compared for demographics, tumor type, presence of germline pathogenic/likely pathogenic (P/LP) variant, and whether NCCN criteria were met for hereditary cancer genetic testing. Germline P/LP variants were common in both groups. Patients who received germline testing through traditional genetic counseling were more likely to have cardinal hereditary tumors than the tumor DNA safety net group. Patients identified with hereditary cancer through traditional genetic counseling were more likely to meet NCCN personal/family history criteria for germline testing than the tumor DNA safety net group (99% versus 34%). A universal tumor DNA safety net screen is an important diagnostic strategy which augments traditional genetic counseling approaches based on personal/family history.\u003c/jats:p\u003e",
  "alternative-id": [
    "317"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "14 January 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "7 September 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "20 October 2022"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "All study design, data acquisition, and data analysis was performed in accordance with approval and oversight by the KPSC Institutional Review Board. The KPSC Institutional Review Board waived the requirement for written or verbal consent due to the deidentified nature of the data, which were extracted from electronic medical records. The authors did not receive support from any organization for the submitted work. The authors have no relevant financial or non-financial interests to disclose."
    },
    {
      "group": {
        "label": "Disclosure:",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare no conflict of interest."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-1612-0213",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Hoffman",
      "given": "Trevor L.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Kershberg",
      "given": "Hilary",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Goff",
      "given": "John",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Holmquist",
      "given": "Kimberly J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Haque",
      "given": "Reina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Alvarado",
      "given": "Monica",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        10,
        20
      ]
    ],
    "date-time": "2022-10-20T02:02:39Z",
    "timestamp": 1666231359000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        3,
        16
      ]
    ],
    "date-time": "2023-03-16T09:21:25Z",
    "timestamp": 1678958485000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        3,
        17
      ]
    ],
    "date-time": "2023-03-17T04:19:31Z",
    "timestamp": 1679026771854
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2022,
        10,
        20
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2023,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            10,
            20
          ]
        ],
        "date-time": "2022-10-20T00:00:00Z",
        "timestamp": 1666224000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            10,
            20
          ]
        ],
        "date-time": "2022-10-20T00:00:00Z",
        "timestamp": 1666224000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-022-00317-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-022-00317-w/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-022-00317-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "225-235",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2022,
        10,
        20
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        10,
        20
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2023,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1007/s10620-015-3964-6",
      "author": "SM Vindigni",
      "doi-asserted-by": "publisher",
      "first-page": "969",
      "journal-title": "Dig Dis Sci",
      "key": "317_CR1",
      "unstructured": "Vindigni SM, Kaz AM (2016) Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities. Dig Dis Sci 61:969–976. https://doi.org/10.1007/s10620-015-3964-6",
      "volume": "61",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41576-021-00338-8",
      "author": "D Chakravarty",
      "doi-asserted-by": "publisher",
      "first-page": "483",
      "journal-title": "Nat Rev Genet",
      "key": "317_CR2",
      "unstructured": "Chakravarty D, Solit DB (2021) Clinical cancer genomic profiling. Nat Rev Genet 22:483–501. https://doi.org/10.1038/s41576-021-00338-8",
      "volume": "22",
      "year": "2021"
    },
    {
      "DOI": "10.1200/JCO.20.03661",
      "author": "ZK Stadler",
      "doi-asserted-by": "publisher",
      "first-page": "2698",
      "journal-title": "J Clin Oncol",
      "key": "317_CR3",
      "unstructured": "Stadler ZK, Maio A, Chakravarty D, Kemel Y, Sheehan M, Salo-Mullen E, Tkachuk K, Fong CJ, Nguyen B, Erakky A, Cadoo K, Liu Y, Carlo MI, Latham A, Zhang H, Kundra R, Smith S, Galle J, Aghajanian C, Abu-Rustum N, Varghese A, O’Reilly EM, Morris M, Abida W, Walsh M, Drilon A, Jayakumaran G, Zehir A, Ladanyi M, Ceyhan-Birsoy O, Solit DB, Schultz N, Berger MF, Mandelker D, Diaz LA, Offit K, Robson ME (2021) Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. J Clin Oncol 39:2698–2709. https://doi.org/10.1200/JCO.20.03661",
      "volume": "39",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.cell.2018.03.039",
      "doi-asserted-by": "publisher",
      "key": "317_CR4",
      "unstructured": "Huang K-L, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, Paczkowska M, Reynolds S, Wyczalkowski MA, Oak N, Scott AD, Krassowski M, Cherniack AD, Houlahan KE, Jayasinghe R, Wang L-B, Zhou DC, Liu D, Cao S, Kim YW, Koire A, McMichael JF, Hucthagowder V, Kim T-B, Hahn A, Wang C, McLellan MD, Al-Mulla F, Johnson KJ, Cancer Genome Atlas Research Network, Lichtarge O, Boutros PC, Raphael B, Lazar AJ, Zhang W, Wendl MC, Govindan R, Jain S, Wheeler D, Kulkarni S, Dipersio JF, Reimand J, Meric-Bernstam F, Chen K, Shmulevich I, Plon SE, Chen F, Ding L (2018) Pathogenic Germline Variants in 10,389 Adult Cancers, Cell. 173:355–370e14. https://doi.org/10.1016/j.cell.2018.03.039"
    },
    {
      "key": "317_CR5",
      "unstructured": "NCCN Guidelines Version (2021) : Genetic Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, (n.d.). www.nccn.org"
    },
    {
      "key": "317_CR6",
      "unstructured": "NCCN Guidelines Version (2021) : Genetic/Familial High-Risk Assessment: Colorectal, (n.d.). www.nccn.org"
    },
    {
      "DOI": "10.1016/j.jmoldx.2021.08.005",
      "author": "SA Tomlins",
      "doi-asserted-by": "publisher",
      "first-page": "1515",
      "journal-title": "J Mol Diagn",
      "key": "317_CR7",
      "unstructured": "Tomlins SA, Hovelson DH, Harms P, Drewery S, Falkner J, Fischer A, Hipp J, Kwiatkowski K, Lazo L, de la Vega K, Mitchell T, Reeder J, Siddiqui H, Vakil DB, Johnson DR, Rhodes (2021) Development and Validation of StrataNGS, a Multiplex PCR, Semiconductor Sequencing-Based Comprehensive Genomic Profiling Test. J Mol Diagn 23:1515–1533. https://doi.org/10.1016/j.jmoldx.2021.08.005",
      "volume": "23",
      "year": "2021"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Genet Med",
      "key": "317_CR8",
      "unstructured": "Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424. https://doi.org/10.1038/gim.2015.30",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1001/jama.2016.1952",
      "author": "D Chavalarias",
      "doi-asserted-by": "publisher",
      "first-page": "1141",
      "journal-title": "JAMA",
      "key": "317_CR9",
      "unstructured": "Chavalarias D, Wallach JD, Li AHT, Ioannidis JPA (2016) Evolution of Reporting P Values in the Biomedical Literature, 1990–2015. JAMA 315:1141–1148. https://doi.org/10.1001/jama.2016.1952",
      "volume": "315",
      "year": "2016"
    },
    {
      "DOI": "10.1002/cncr.32740",
      "author": "H Maynard",
      "doi-asserted-by": "publisher",
      "first-page": "1995",
      "journal-title": "Cancer",
      "key": "317_CR10",
      "unstructured": "Maynard H, Stadler ZK, Berger MF, Solit DB, Ly M, Lowery MA, Mandelker D, Zhang L, Jordan E, El Dika I, Kemel Y, Ladanyi M, Robson ME, O’Reilly EM (2020) Abou-Alfa, Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings. Cancer 126:1995–2002. https://doi.org/10.1002/cncr.32740",
      "volume": "126",
      "year": "2020"
    },
    {
      "DOI": "10.1200/PO.19.00359",
      "doi-asserted-by": "publisher",
      "key": "317_CR11",
      "unstructured": "Bitzer M, Ostermann L, Horger M, Biskup S, Schulze M, Ruhm K, Hilke F, Öner Ö, Nikolaou K, Schroeder C, Riess O, Fend F, Zips D, Hinterleitner M, Zender L, Tabatabai G, Beha J, Malek NP(2020) Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment Options, JCO Precis Oncol. 4 PO.19.00359. https://doi.org/10.1200/PO.19.00359"
    },
    {
      "DOI": "10.1200/JCO.19.01395",
      "author": "MI Carlo",
      "doi-asserted-by": "publisher",
      "first-page": "406",
      "journal-title": "J Clin Oncol",
      "key": "317_CR12",
      "unstructured": "Carlo MI, Ravichandran V, Srinavasan P, Bandlamudi C, Kemel Y, Ceyhan-Birsoy O, Mukherjee S, Mandelker D, Chaim J, Knezevic A, Rana S, Fnu Z, Breen K, Arnold AG, Khurram A, Tkachuk K, Cipolla CK, Regazzi A, Hakimi AA, Al-Ahmadie H, Dalbagni G, Cadoo KA, Walsh MF, Teo M-Y, Funt SA, Coleman JA, Bochner BH, Iyer G, Solit DB, Stadler ZK, Zhang L, Rosenberg JE, Taylor BS, Robson ME, Berger MF, Vijai J, Bajorin DF, Offit K (2020) Cancer Susceptibility Mutations in Patients With Urothelial Malignancies. J Clin Oncol 38:406–414. https://doi.org/10.1200/JCO.19.01395",
      "volume": "38",
      "year": "2020"
    },
    {
      "DOI": "10.3389/fonc.2019.00550",
      "doi-asserted-by": "publisher",
      "key": "317_CR13",
      "unstructured": "Sun S, Liu Y, Eisfeld A-K, Zhen F, Jin S, Gao W, Yu T, Chen L, Wang W, Chen W, Yuan M, Chen R, He K, Guo R (2019) Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study, Front Oncol. 9:550. https://doi.org/10.3389/fonc.2019.00550"
    },
    {
      "DOI": "10.21147/j.issn.1000-9604.2020.04.08",
      "author": "K Ji",
      "doi-asserted-by": "publisher",
      "first-page": "508",
      "journal-title": "Chin J Cancer Res",
      "key": "317_CR14",
      "unstructured": "Ji K, Ao S, He L, Zhang L, Feng L, Lyu G (2020) Characteristics of cancer susceptibility genes mutations in 282 patients with gastric adenocarcinoma. Chin J Cancer Res 32:508–515. https://doi.org/10.21147/j.issn.1000-9604.2020.04.08",
      "volume": "32",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.lungcan.2009.11.007",
      "author": "Y-L Lo",
      "doi-asserted-by": "publisher",
      "first-page": "148",
      "journal-title": "Lung Cancer",
      "key": "317_CR15",
      "unstructured": "Lo Y-L, Hsiao C-F, Jou Y-S, Chang G-C, Tsai Y-H, Su W-C, Chen Y-M, Huang M-S, Chen H-L, Yang P-C, Chen C-J, Hsiung CA (2010) ATM polymorphisms and risk of lung cancer among never smokers. Lung Cancer 69:148–154. https://doi.org/10.1016/j.lungcan.2009.11.007",
      "volume": "69",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s41598-017-07737-0",
      "author": "J Wang",
      "doi-asserted-by": "publisher",
      "first-page": "8371",
      "journal-title": "Sci Rep",
      "key": "317_CR16",
      "unstructured": "Wang J, Liu Q, Yuan S, Xie W, Liu Y, Xiang Y, Wu N, Wu L, Ma X, Cai T, Zhang Y, Sun Z, Li Y (2017) Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies. Sci Rep 7:8371. https://doi.org/10.1038/s41598-017-07737-0",
      "volume": "7",
      "year": "2017"
    },
    {
      "DOI": "10.21037/tlcr-19-403",
      "author": "M Liu",
      "doi-asserted-by": "publisher",
      "first-page": "646",
      "journal-title": "Transl Lung Cancer Res",
      "key": "317_CR17",
      "unstructured": "Liu M, Liu X, Suo P, Gong Y, Qu B, Peng X, Xiao W, Li Y, Chen Y, Zeng Z, Lu Y, Huang T, Zhao Y, Liu M, Li L, Chen Y, Zhou Y, Liu G, Yao J, Chen S, Song L (2020) The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility. Transl Lung Cancer Res 9:646–658. https://doi.org/10.21037/tlcr-19-403",
      "volume": "9",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.ejca.2006.09.024",
      "author": "S Manoukian",
      "doi-asserted-by": "publisher",
      "first-page": "601",
      "journal-title": "Eur J Cancer",
      "key": "317_CR18",
      "unstructured": "Manoukian S, Peissel B, Pensotti V, Barile M, Cortesi L, Stacchiotti S, Terenziani M, Barbera F, Pasquini G, Frigerio S, Pierotti MA, Radice P, Della-Torre G (2007) Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families. Eur J Cancer 43:601–606. https://doi.org/10.1016/j.ejca.2006.09.024",
      "volume": "43",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S1470-2045(16)30147-4",
      "author": "ML Ballinger",
      "doi-asserted-by": "publisher",
      "first-page": "1261",
      "journal-title": "Lancet Oncol",
      "key": "317_CR19",
      "unstructured": "Ballinger ML, Goode DL, Ray-Coquard I, James PA, Mitchell G, Niedermayr E, Puri A, Schiffman JD, Dite GS, Cipponi A, Maki RG, Brohl AS, Myklebost O, Stratford EW, Lorenz S, Ahn S-M, Ahn J-H, Kim JE, Shanley S, Beshay V, Randall RL, Judson I, Seddon B, Campbell IG, Young M-A, Sarin R, Blay J-Y, O’Donoghue SI, Thomas DM (2016) International Sarcoma Kindred Study, Monogenic and polygenic determinants of sarcoma risk: an international genetic study. Lancet Oncol 17:1261–1271. https://doi.org/10.1016/S1470-2045(16)30147-4",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1158/1940-6207.CAPR-20-0448",
      "author": "MJ Hall",
      "doi-asserted-by": "publisher",
      "first-page": "433",
      "journal-title": "Cancer Prev Res (Phila)",
      "key": "317_CR20",
      "unstructured": "Hall MJ, Bernhisel R, Hughes E, Larson K, Rosenthal ET, Singh NA, Lancaster JM, Kurian AW (2021) Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (ATM) Gene are Associated with High and Moderate Risks for Multiple Cancers. Cancer Prev Res (Phila) 14:433–440. https://doi.org/10.1158/1940-6207.CAPR-20-0448",
      "volume": "14",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s12687-020-00456-6",
      "author": "M Alvarado",
      "doi-asserted-by": "publisher",
      "first-page": "359",
      "journal-title": "J Community Genet",
      "key": "317_CR21",
      "unstructured": "Alvarado M, Tiller GE, Chung J, Haque R (2020) Prevalence of mutations in a diverse cohort of 3162 women tested via the same multigene cancer panel in a managed care health plan. J Community Genet 11:359–366. https://doi.org/10.1007/s12687-020-00456-6",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41525-019-0087-6",
      "author": "B Bertelsen",
      "doi-asserted-by": "publisher",
      "first-page": "13",
      "journal-title": "NPJ Genom Med",
      "key": "317_CR22",
      "unstructured": "Bertelsen B, Tuxen IV, Yde CW, Gabrielaite M, Torp MH, Kinalis S, Oestrup O, Rohrberg K, Spangaard I, Santoni-Rugiu E, Wadt K, Mau-Sorensen M, Lassen U, Nielsen FC (2019) High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer. NPJ Genom Med 4:13. https://doi.org/10.1038/s41525-019-0087-6",
      "volume": "4",
      "year": "2019"
    },
    {
      "DOI": "10.1093/jncics/pkaa018",
      "doi-asserted-by": "publisher",
      "key": "317_CR23",
      "unstructured": "Klek S, Heald B, Milinovich A, Ni Y, Abraham J, Mahdi H, Estfan B, Khorana AA, Bolwell BJ, Grivas P, Sohal DPS, Funchain P (2020) Genetic Counseling and Germline Testing in the Era of Tumor Sequencing: A Cohort Study, JNCI Cancer Spectr. 4:pkaa018. https://doi.org/10.1093/jncics/pkaa018"
    },
    {
      "DOI": "10.1001/jama.2017.11137",
      "doi-asserted-by": "publisher",
      "key": "317_CR24",
      "unstructured": "Mandelker D, Zhang L, Kemel Y, Stadler ZK, Joseph V, Zehir A, Pradhan N, Arnold A, Walsh MF, Li Y, Balakrishnan AR, Syed A, Prasad M, Nafa K, Carlo MI, Cadoo KA, Sheehan M, Fleischut MH, Salo-Mullen E, Trottier M, Lipkin SM, Lincoln A, Mukherjee S, Ravichandran V, Cambria R, Galle J, Abida W, Arcila ME, Benayed R, Shah R, Yu K, Bajorin DF, Coleman JA, Leach SD, Lowery MA, Garcia-Aguilar J, Kantoff PW, Sawyers CL, Dickler MN, Saltz L, Motzer RJ, O’Reilly EM, Scher HI, Baselga J, Klimstra DS, Solit DB, Hyman DM, Berger MF, Ladanyi M, Robson ME, Offit K(2017) Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing, JAMA. 318 825–835. https://doi.org/10.1001/jama.2017.11137"
    },
    {
      "DOI": "10.1093/annonc/mdw018",
      "author": "F Meric-Bernstam",
      "doi-asserted-by": "publisher",
      "first-page": "795",
      "journal-title": "Ann Oncol",
      "key": "317_CR25",
      "unstructured": "Meric-Bernstam F, Brusco L, Daniels M, Wathoo C, Bailey AM, Strong L, Shaw K, Lu K, Qi Y, Zhao H, Lara-Guerra H, Litton J, Arun B, Eterovic AK, Aytac U, Routbort M, Subbiah V, Janku F, Davies MA, Kopetz S, Mendelsohn J, Mills GB, Chen K (2016) Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol. Ann Oncol 27:795–800. https://doi.org/10.1093/annonc/mdw018",
      "volume": "27",
      "year": "2016"
    },
    {
      "DOI": "10.1001/jamaoncol.2020.6252",
      "author": "NJ Samadder",
      "doi-asserted-by": "publisher",
      "first-page": "230",
      "journal-title": "JAMA Oncol",
      "key": "317_CR26",
      "unstructured": "Samadder NJ, Riegert-Johnson D, Boardman L, Rhodes D, Wick M, Okuno S, Kunze KL, Golafshar M, Uson PLS, Mountjoy L, Ertz-Archambault N, Patel N, Rodriguez EA, Lizaola-Mayo B, Lehrer M, Thorpe CS, Yu NY, Esplin ED, Nussbaum RL, Sharp RR, Azevedo C, Klint M, Hager M, Macklin-Mantia S, Bryce AH, Bekaii-Saab TS, Sekulic A, Stewart AK (2021) Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome. JAMA Oncol 7:230–237. https://doi.org/10.1001/jamaoncol.2020.6252",
      "volume": "7",
      "year": "2021"
    },
    {
      "DOI": "10.1001/jamanetworkopen.2020.19452",
      "author": "SE Lincoln",
      "doi-asserted-by": "publisher",
      "first-page": "e2019452",
      "journal-title": "JAMA Netw Open",
      "key": "317_CR27",
      "unstructured": "Lincoln SE, Nussbaum RL, Kurian AW, Nielsen SM, Das K, Michalski S, Yang S, Ngo N, Blanco A, Esplin ED (2020) Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer. JAMA Netw Open 3:e2019452. https://doi.org/10.1001/jamanetworkopen.2020.19452",
      "volume": "3",
      "year": "2020"
    },
    {
      "DOI": "10.1200/PO.19.00076",
      "doi-asserted-by": "publisher",
      "key": "317_CR28",
      "unstructured": "Clark DF, Maxwell KN, Powers J, Lieberman DB, Ebrahimzadeh J, Long JM, McKenna D, Shah P, Bradbury A, Morrissette JJD, Nathanson KL, Domchek SM (2019) Identification and Confirmation of Potentially Actionable Germline Mutations in Tumor-Only Genomic Sequencing, JCO Precis Oncol. 3. https://doi.org/10.1200/PO.19.00076"
    },
    {
      "DOI": "10.1093/annonc/mdz136",
      "author": "D Mandelker",
      "doi-asserted-by": "publisher",
      "first-page": "1221",
      "journal-title": "Ann Oncol",
      "key": "317_CR29",
      "unstructured": "Mandelker D, Donoghue M, Talukdar S, Bandlamudi C, Srinivasan P, Vivek M, Jezdic S, Hanson H, Snape K, Kulkarni A, Hawkes L, Douillard J-Y, Wallace SE, Rial-Sebbag E, Meric-Bersntam F, George A, Chubb D, Loveday C, Ladanyi M, Berger MF, Taylor BS, Turnbull C (2019) Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group. Ann Oncol 30:1221–1231. https://doi.org/10.1093/annonc/mdz136",
      "volume": "30",
      "year": "2019"
    }
  ],
  "reference-count": 29,
  "references-count": 29,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-022-00317-w"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "22"
}